Jean Jacques Bienaime
Director at Ascendis Pharma A/S (ASND); Director at Immunome Inc. (IMNM); Director at Keros Therapeutics, Inc. (KROS)
Purchase track record
Above average. Based on 9 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 19SEC | KROSKeros Therapeutics, Inc. | Buy | 1,00019,592 held (+5%) | $10.27 | $10K | +16.4% |
| Aug 18SEC | ASNDAscendis Pharma A/S | Buy | 1,1002,000 held (+122%) | $245.85 | $270K | -6.8% |
| Aug 18SEC | ASNDAscendis Pharma A/S | Buy | 9002,900 held (+45%) | $246.91 | $222K | -7.2% |
| Jul 17SEC | KROSKeros Therapeutics, Inc. | Buy | 1,00018,592 held (+6%) | $10.61 | $11K | +12.6% |
| Jun 17SEC | KROSKeros Therapeutics, Inc. | Buy | 1,00017,592 held (+6%) | $10.19 | $10K | +17.3% |
| Jun 9SEC | IMNMImmunome Inc. | Sell | 50042,915 held (−1%) | $19.44 | $10K | +0.6% |
| Jun 9SEC | IMNMImmunome Inc. | Sell | 10,00032,915 held (−23%) | $19.41 | $194K | +0.7% |
| Jun 9SEC | IMNMImmunome Inc. | Buy | 6,00038,915 held (+18%) | $19.48 | $117K | +0.4% |
| Jun 9SEC | IMNMImmunome Inc. | Buy | 3,50042,415 held (+9%) | $19.46 | $68K | +0.5% |
| Jun 9SEC | IMNMImmunome Inc. | Buy | 1,00043,415 held (+2%) | $19.27 | $19K | +1.5% |
| Jun 1SEC | ASNDAscendis Pharma A/S | Buy | 200600 held (+50%) | $223.76 | $45K | +2.4% |
| Jun 1SEC | ASNDAscendis Pharma A/S | Buy | 200800 held (+33%) | $222.30 | $44K | +3.1% |
| Jun 1SEC | ASNDAscendis Pharma A/S | Buy | 100900 held (+12%) | $223.50 | $22K | +2.6% |
| May 27SEC | ASNDAscendis Pharma A/S | Buy | 200new position | $236.24 | $47K | -3.0% |
| May 27SEC | ASNDAscendis Pharma A/S | Buy | 200400 held (+100%) | $239.37 | $48K | -4.2% |
| May 19SEC | IMNMImmunome Inc. | Buy | 5,00043,415 held (+13%) | $20.70 | $104K | -5.6% |
| May 19SEC | KROSKeros Therapeutics, Inc. | Buy | 1,0009,450 held (+12%) | $10.58 | $11K | +12.9% |
| Apr 17SEC | KROSKeros Therapeutics, Inc. | Buy | 1,0008,450 held (+13%) | $11.70 | $12K | +2.1% |
| Mar 12SEC | IMNMImmunome Inc. | Buy | 1,00037,415 held (+3%) | $22.12 | $22K | -11.6% |
| Mar 12SEC | IMNMImmunome Inc. | Buy | 1,00038,415 held (+3%) | $21.55 | $22K | -9.3% |
| Mar 11SEC | KROSKeros Therapeutics, Inc. | Buy | 2,0007,450 held (+37%) | $11.21 | $22K | +6.6% |
- Buy
Director Jean Jacques Bienaime bought $270K of ASND at $245.85 — largest purchase by this insider in our records; raises the stake by 122%.
- Buy
Director Jean Jacques Bienaime bought $222K of ASND at $246.91 — raises the stake by 45%.
- Buy
Director Jean Jacques Bienaime bought $117K of IMNM at $19.48 — largest purchase by this insider in our records.
- Buy
Director Jean Jacques Bienaime bought $45K of ASND at $223.76 — raises the stake by 50%.
- Buy
Director Jean Jacques Bienaime bought $44K of ASND at $222.30 — raises the stake by 33%.
- Buy
Director Jean Jacques Bienaime bought $47K of ASND at $236.24 — first open-market purchase in our records; opens a new position.